CIK 0001761612
- Non-accelerated filer
- Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Grant or award Director acquired 5,750 shares (grant or award)
- 4 Grant or award Director acquired 5,750 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 6,000 shares at $29.06 ($174,360)
- 4 Grant or award Director acquired 11,500 shares (grant or award)
- 4 Exercise or conversion Chief Operating Officer acquired 5,155 shares (option exercise)
- 3/A Insider 3/A
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 15,000 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 15,000 shares (grant or award)
- 4 Grant or award President and CFO acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 15,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 9 of 16 · 304 filings